Inhibitory potential against oral squamous cancer cells demonstrated by amyloid beta peptide (s)/doxorubicin (DOX) conjugates
Saved in:
Main Author: | Rethinam Senthil |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024001900 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
by: Rethinam Senthil, et al.
Published: (2024-03-01) -
Ruthenium (Ru) complex conjugates drugs and targeted tumors by inhibiting oral cancer cells
by: Rethinam Senthil
Published: (2024-06-01) -
Inhibitory Effect of Curcumin-Cu(II) and Curcumin-Zn(II) Complexes on Amyloid-Beta Peptide Fibrillation
by: Rona Banerjee
Published: (2014-01-01) -
Reduced-graphene oxide (R-GO) conjugated methotrexate (MTX) killing of oral cancer cells
by: Rethinam Senthil
Published: (2024-06-01) -
Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease
by: Mallory Gough, et al.
Published: (2011-01-01)